GCG and type 2 diabetes mellitus: Therefore, the present study explored the structural changes in LDOP‐A after oral administration and its effect on promoting SCFAs production and GLP‐1 secretion, thus providing new evidence for LDOP‐A as anti‐T2DM medicated diet for patients.